Nakamura, Akifumi Hashimoto, Masaki Kodama, Hiroshi Yuki, Michiko Kondo, Nobuyuki Yamakado, Koichiro Tsujimura, Tohru Kijima, Takashi Hasegawa, Seiki
Published in
International journal of clinical oncology
We occasionally encounter malignant pleural mesothelioma (MPM) of no apparent tumor or pleural thickening that is radiological early MPM. This study aimed to examine the clinicopathological outcomes of radiological early MPM. Patients with MPM treated with neoadjuvant chemotherapy and planned surgery at the time of diagnosis between July 2004 and D...
Yoshida, Yoichiro Yamada, Takeshi Kamiyama, Hirohiko Kosugi, Chihiro Ishibashi, Keiichiro Yoshida, Hiroshi Ishida, Hideyuki Yamaguchi, Satoru Kuramochi, Hidekazu Fukazawa, Atsuko
...
Published in
International journal of clinical oncology
TAS-102 improved the overall survival of metastatic colorectal cancer (CRC) patients with a median progression-free survival (PFS) in the RECOURSE trial. Subsequently, the combination of TAS-102 and bevacizumab was shown to extend the median PFS (C-TASK FORCE study). However, the study included patients who received second- and third-line treatment...
Endoh, Hideki Ichikawa, Akihiro Yamamoto, Ryohei Shiozawa, Satoshi Nishizawa, Nobuhiro Satoh, Yukitoshi Oriuchi, Noboru
Published in
International journal of clinical oncology
2-[18F] Fluoro-D-deoxyglucose positron emission tomography (FDG-PET) is an appropriate diagnostic procedure for staging lung cancer. However, accurate evaluation of lymph node (LN) metastases by PET is controversial owing to false-positive/-negative FDG uptake results. The prognostic significance of both false-negative and false-positive LNs on FDG...
Nagao, Shoji Yamamoto, Kasumi Oishi, Tetsuro Yamaguchi, Satoshi Takehara, Kazuhiro Shimada, Muneaki Kigawa, Junzo
Published in
International journal of clinical oncology
We proposed a novel treatment strategy, consisting of triweekly cisplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy without adjuvant radiation therapy to treat locally advanced cervical cancer. However, cisplatin-related severe non-hematologic toxicities were frequent during this strategy. This study aimed to assess th...
Altan, Mesut Haberal, Hakan Bahadır Aşçı, Ahmet Güdeloğlu, Ahmet Doğrul, Ahmet Bülent Yazıcı, Mustafa Sertaç Akdoğan, Bülent Özen, Haluk
Published in
International journal of clinical oncology
To assess the clinical variables that effect progression in patients with viable tumor after post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors. We performed a retrospective analysis of 32 patients with viable tumor after PC-RPLND, operated between 1990 and 2016. Patients were categorized into 2 groups as ...
Tang, Min Jia, Zhongxiong Zhang, Ju
Published in
International journal of clinical oncology
The prognostic utility of the prognostic nutritional index (PNI) in nasopharyngeal carcinoma (NPC) has never been systematically reviewed. Therefore, we performed this meta-analysis. We performed comprehensive research via Embase, PubMed, Web of Science and the Cochrane Library. The pooled hazard ratios (HRs) and odds ratios (ORs) with 95% confiden...
Song, Hyun Jin Rhew, Kiyon Lee, Yoon Jae Ha, In-Hyuk
Published in
International journal of clinical oncology
Patients with cancer often receive acid-suppressive agents (ASAs) to treat common gastroesophageal reflux and peptic ulcer diseases. Our systematic review addresses the association between ASAs and survival outcomes in these patients. We searched MEDLINE, EMBASE, and Cochrane until December 2019, including randomized controlled trials (RCTs), quasi...
Yamamoto, Yoshiaki Yatsuda, Junji Shimokawa, Mototsugu Fuji, Nakanori Aoki, Akihiko Sakano, Shigeru Yamamoto, Mitsutaka Suga, Akinobu Tei, Yasuhide Yoshihiro, Satoru
...
Published in
International journal of clinical oncology
Pembrolizumab is effective in a limited number of patients with advanced urothelial carcinoma (UC). Therefore, we evaluated the prognostic value of clinical biomarkers following pembrolizumab treatment in patients with advanced UC. We retrospectively reviewed the medical records of 121 patients with platinum-refractory advanced UC who received pemb...
Okugawa, Kaoru Yahata, Hideaki Sonoda, Kenzo Kodama, Keisuke Yagi, Hiroshi Ohgami, Tatsuhiro Yasunaga, Masafumi Onoyama, Ichiro Kaneki, Eisuke Asanoma, Kazuo
...
Published in
International journal of clinical oncology
To avoid the loss of fertility, chemotherapy should be chosen as an adjuvant treatment after trachelectomy. Our study evaluated the effectiveness and safety of adjuvant chemotherapy after abdominal trachelectomy for cervical cancer. Our institutional review board approved this clinical study, and informed consent was obtained from each patient. We ...
Harada, Toshiyuki Imai, Hisao Fumita, Soichi Noriyuki, Toshio Gamoh, Makio Okamoto, Masaharu Akashi, Yusaku Kizawa, Yoshiyuki Tokoro, Akihiro
Published in
International journal of clinical oncology
Constipation is a common side effect of opioid therapy. An observational study of opioid-induced constipation (OIC) in Japanese patients with cancer (OIC-J) included 212 patients with various tumor types. This post hoc analysis of OIC-J evaluated a subgroup of patients with gastrointestinal (GI) cancer. Patients were aged ≥ 20 years, starting stron...
